QPP Measure #AAO23
Percentage of patients with allergic rhinitis who are offered intranasal corticosteroids or oral antihistamines
This measure is intended to decrease variability in management of allergic rhinitis by clinicians and encouraging the use of intranasal steroids or oral antihistamines for treatment of allergic rhinitis as first line treatment.
Submission Methods: Registry
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com